News

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference

INmune Bio Inc. (NASDAQ: INMB) announced today that additional analyses from its Phase 2 MINDFuL trial evaluating XPro™, a novel selective soluble TNF inhibitor, will be released in an oral ...

Pink Salt Trick Recipe to Weight Loss Trend 2025: An Analysis of Slumber Slim as a Science Informed Option

The viral, weight loss TikTok trend Pink Salt Trick is not scientific; Slumber Slim has a scientifically backed alternative ...

Heritage Commerce Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Second Quarter 2025 Results Key Financial Results Revenue: US$47.3m (up 15% from ...

FTSE 100 takes breather and US markets higher following record setting-week

Investors assessed a packed week of major earnings, trade deals, and Donald Trump's unusual visit to the Federal Reserve and ...

Growth, buybacks and dividends galore – are NatWest shares the ultimate no-brainer buy?

NatWest shares are flying again, as we saw in its expectation-thrashing results. Harvey Jones looks at whether the FTSE 100 ...